BullFrog AI Holdings, Inc. (BFRG): R&D Expense
$1.80M
Year ended 2025-12-31
$1.52M
Trailing 12 months to 2026-06-30
+43.5%
3-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.80M | -19.0% | 2026-03-19, From 2025-01-01 |
| 2024-12-31 | $2.22M | +55.2% | 2026-03-19, From 2024-01-01 |
| 2023-12-31 | $1.43M | +135.1% | 2025-03-14, From 2023-01-01 |
| 2022-12-31 | $609.3K | n/m | 2024-03-29, From 2022-01-01 |
| 2021-12-31 | $25.0K | n/a | 2023-04-25, From 2021-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $1.80M | -19.0% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $13.15M | +75.9% |
| iBio, Inc. (IBIO) | 2026-06-30 | $19.64M | +136.3% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $21.12M | -29.7% |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $10.75M | -16.6% |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $7.95M | -29.9% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $2.16M | -8.8% |
| Clene Inc. (CLNN) | 2025-12-31 | $14.01M | -30.1% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $54.21M | -28.3% |
Compare BFRG, SER, IBIO, ATNM side by side · Screen every company in Pharmaceutical Preparations ↗